Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D. Blech & Co. was a pioneering boutique investment bank and venture capital firm that played a critical role in the early development of the biotechnology industry. Founded by David Blech in the late 1980s, the firm was responsible for financing and founding numerous high-profile biotech companies, including Celgene, Alexion Pharmaceuticals, and ICOS Corporation. At its peak, it was one of the most influential financiers in the sector, known for its aggressive venture-banking model that provided early-stage capital to nascent life science startups. The firm collapsed in 1994 following a liquidity crisis, but its legacy remains through the many successful life science companies it helped establish. It is historically significant for its role in shaping the modern biotech financial landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on D. Blech and Co.